Isto Biologics:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Isto Biologics - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6460
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Isto Biologics is an orthobiologics company which manufactures and develops biological products to treat orthopedic and spine disorders. The company offers solutions in cell therapy, bone healing and regeneration that harness cells and proteins naturally found in human biology which support the regrowth of musculoskeletal tissues, including cartilage, bone, tendons, and ligaments. Its products portfolio includes InQu, a bone graft extender and substitute that is a biosynthetic bone graft; Magellan, an autologous platelet separator; and CellPoint, a concentrated bone marrow aspirate system, and Influx, a trabecular bone graft. Isto Biologics’ patented biosynthetic platform is utilized in the InQu bone graft which is composed of synthetic poly (lactide-co-glycolide) (PLGA) combined with hyaluronic acid (HyA). The company is an integration between Isto Technologies, Inc and Arteriocyte Medical Systems, Inc. Isto Biologics is headquartered in St. Louis, Missouri, the US.

Isto Biologics – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Isto Biologics , Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Isto Biologics , Medical Equipment Deals By Type, 2012 to YTD 2018 6
Isto Biologics , Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Isto Biologics , Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Isto Biologics , Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Isto Biologics , Medical Equipment, Deal Details 10
Venture Financing 10
Isto Technologies Raises US$8 Million In Venture Financing 10
Isto Technologies Raises US$2 Million In Venture Financing 11
Private Equity 12
Thompson Street Capital Partners Acquires Commercial Operations of ISTO Tech 12
Acquisition 13
Isto Acquires Arteriocyte Medical Systems 13
Isto Biologics – Key Competitors 14
Isto Biologics – Key Employees 15
Isto Biologics – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Isto Biologics , Medical Equipment, Key Facts 2
Isto Biologics , Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Isto Biologics , Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Isto Biologics , Medical Equipment Deals By Type, 2012 to YTD 2018 6
Isto Biologics , Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Isto Biologics , Deals By Market, 2012 to YTD 2018 8
Isto Biologics , Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Isto Technologies Raises US$8 Million In Venture Financing 10
Isto Technologies Raises US$2 Million In Venture Financing 11
Thompson Street Capital Partners Acquires Commercial Operations of ISTO Tech 12
Isto Acquires Arteriocyte Medical Systems 13
Isto Biologics , Key Competitors 14
Isto Biologics , Key Employees 15
Isto Biologics , Other Locations 16
Isto Biologics , Subsidiaries 16

List of Figures
Isto Biologics , Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Isto Biologics , Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Isto Biologics , Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Isto Biologics , Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Isto Biologics , Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Isto Biologics , Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Isto Biologics , Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Isto Biologics , Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Isto Biologics:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Gentag Inc:医療機器:M&Aディール及び事業提携情報
    Summary Gentag Inc (Gentag) is a medical device company that patent and develops wireless sensor technology products. The company provides wireless products to diagnostics and personal health. It offers wireless sensor network services. Gentag’s products comprise medication and packaging sensor, dia …
  • WEC Energy Group Inc (WEC)-エネルギー分野:企業M&A・提携分析
    Summary WEC Energy Group, Inc. (WEC) is a diversified holding company that carries out the generation and distribution of electricity in southeastern Wisconsin, east central Wisconsin, northern Wisconsin, and Michigan's Upper Peninsula; and transports and distributes natural gas in the upper peninsu …
  • Karelia Tobacco Company Inc SA:企業の戦略・SWOT・財務情報
    Karelia Tobacco Company Inc SA - Strategy, SWOT and Corporate Finance Report Summary Karelia Tobacco Company Inc SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Xbrane Biopharma AB (XBRANE):企業の財務・戦略的SWOT分析
    Summary Xbrane Biopharma AB (Xbrane), formerly Xbrane Bioscience AB is a biopharmaceutical company that develops and manufactures complex generic products. The company's product portfolio includes biosimilars and long acting injectables developed for people suffering from critical diseases. It combi …
  • Nokia Corporation:戦略・SWOT・企業財務分析
    Nokia Corporation - Strategy, SWOT and Corporate Finance Report Summary Nokia Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Ascena Retail Group Inc (ASNA):企業の財務・戦略的SWOT分析
    Ascena Retail Group Inc (ASNA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Shenzhen Jinjia Group Co., Ltd.:企業の戦略・SWOT・財務情報
    Shenzhen Jinjia Group Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Shenzhen Jinjia Group Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Catalyst Pharmaceuticals Inc (CPRX):製薬・医療:M&Aディール及び事業提携情報
    Summary Catalyst Pharmaceuticals Inc (Catalyst) is a biopharmaceutical company that develops prescription drugs targeting rare neurological and neuromuscular diseases. The company focuses on specific conditions such as infantile spasms, complex partial seizures, Lambert-Eaton myasthenic syndrome (LE …
  • Mediware Information Systems Inc-医療機器分野:企業M&A・提携分析
    Summary Mediware Information Systems Inc (Mediware) is a healthcare solutions company that designs, develops and commercializes specialized healthcare software. It provides software to healthcare and human service providers and payers. The company’s portfolio of solutions are equipped in blood banks …
  • Sarah Cannon Research Institute LLC-製薬・医療分野:企業M&A・提携分析
    Summary Sarah Cannon Research Institute LLC (SCRI) is a research institute that offers integrated cancer services. The institute conducts clinical research programs for advancing cancer therapies. Its services include blood cancer network, cancer care overview, cardiovascular research, contract rese …
  • AMW GmbH:医療機器:M&Aディール及び事業提携情報
    Summary AMW GmbH (AMW) is a pharmaceutical company that develops and manufactures drug delivery systems for treatment in the areas of oncology, neurology, dermatology and pain. The company designs and develops novel transdermal drug delivery systems, microchip controlled patches and biodegradable su …
  • MITIE Group Plc (MTO):企業の財務・戦略的SWOT分析
    MITIE Group Plc (MTO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Generex Biotechnology Corp (GNBT):企業の財務・戦略的SWOT分析
    Generex Biotechnology Corp (GNBT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Oil and Natural Gas Corporation Ltd (ONGC)-石油・ガス分野:企業M&A・提携分析
    Summary Oil and Natural Gas Corporation Ltd (ONGC) is an integrated oil and gas company. It explores for and produces oil and natural gas; refines crude oil; and markets and distributes petroleum products. The company's product portfolio includes crude oil, natural gas, liquefied natural gas, naphth …
  • Zynex Inc (ZYXI):医療機器:M&Aディール及び事業提携情報
    Summary Zynex Inc (Zynex), formerly Zynex Medical Inc is a medical technology company that designs, manufactures, and markets electrotherapy medical devices used for pain management and rehabilitation. The company’s products include NexWave, a dual channel, multi-modality interferential current, tra …
  • Oric Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Oric Pharmaceuticals Inc (Oric Pharmaceuticals) is an independent oncology company that focuses to discover and develop drugs for overcoming resistance in cancer. Its lead drug candidate ORIC-101, which is in phase 1 clinical trial, is a small molecule inhibitor of the glucocorticoid recepto …
  • Qaf Limited:企業の戦略・SWOT・財務分析
    Qaf Limited - Strategy, SWOT and Corporate Finance Report Summary Qaf Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Shield Therapeutics Plc (STX):企業の財務・戦略的SWOT分析
    Summary Shield Therapeutics Plc (Shield Therapeutics) is a specialty pharmaceutical company that focus on the development and commercialization products for the treatment of anaemia associated with renal and gastrointestinal disorders. The company’s product portfolio includes Feraccru, a stable, non …
  • Presidio Inc (PSDO):企業の財務・戦略的SWOT分析
    Presidio Inc (PSDO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • System Dynamics International Incorporated:企業の戦略・SWOT・財務分析
    System Dynamics International Incorporated - Strategy, SWOT and Corporate Finance Report Summary System Dynamics International Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆